PLEOMORPHIC XANTHOASTROCYTOMA
Clinical trials for PLEOMORPHIC XANTHOASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new PLEOMORPHIC XANTHOASTROCYTOMA trials appear
Sign up with your email to follow new studies for PLEOMORPHIC XANTHOASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tracking Kids' health years after brain tumor treatment
Disease control OngoingThis study follows children and teens who are already taking the medications dabrafenib and/or trametinib for various types of brain tumors. The main goal is to monitor their long-term health, safety, and development while they continue treatment. Researchers will track side effe…
Matched conditions: PLEOMORPHIC XANTHOASTROCYTOMA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Massive brain cancer study aims to map the best path forward after recurrence
Knowledge-focused OngoingThis study aims to understand which treatment sequences work best for patients whose aggressive brain tumors have returned. Researchers will analyze the medical records of about 1,000 patients to see how different chemotherapy and targeted drug combinations affect survival and ti…
Matched conditions: PLEOMORPHIC XANTHOASTROCYTOMA
Sponsor: Blokhin's Russian Cancer Research Center • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC